Activity value 61united states Buyer,Last transaction date:
2021-06-14
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for nylan pharmaceuticals inc. from 2021 to 2022.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
YearTransactionsQuantityWeight
20214304320
2022000
Bill of lading data
<
1/4
>
Trade date
2021/06/14
B/L No.
——
Suppliers
usv ltd.
Buyers
nylan pharmaceuticals inc.
POLs
sahar air cargo acc inbom4
PODs
atlanta hartsfield
1usv ltd.
supplier,they trade on 2021-06-14
4100.00%
>
Products
Total 3
ProductsTransactionsPerDetail
acitretin 4100%>
capsule 4100%>
bat 4100%>
Hscode rank
Total 1
HSCode NameTransactionsPerDetail
HS 300490994100%>
Trading Area
Total 1
AreaTransactionsPerDetail
india4100.00%>
Port statistics
Total 1
Port NameTransactionsPerDetail
atlanta hartsfield250.00%>
nylan pharmaceuticals inc. is united states Buyer,
and primarily engages in the import and export business of products such as acitretin,capsule,bat.
According to the 52wmb.com global trade database, as of 2021-06-14, the company has completed 4 international trades,
with its main trading regions covering india etc.
The core products include HS30049099 etc,
often transported via atlanta hartsfield etc,
and its main trading partners are usv ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on nylan pharmaceuticals inc. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.